Regulatory Group Director
Genentech
Dr Sarah Bentouati, Regulatory Group Director at Genentech, has been working in regulatory affairs for the last 12 years, starting her career in F. Hoffman-La Roche, Basel, Switzerland. After 6 years working on various European and international regulatory procedures, spanning from early phase programs to marketed products, Sarah moved to South San Francisco, USA, to join Genentech in 2016. At Genentech, Sarah took on global roles, leading regulatory affairs functional teams and being accountable for the global regulatory strategy of various projects. Sarah is currently a Regulatory Group Director, focusing on the development of products for the treatment of various gastro-intestinal tumors. In addition, Sarah is a people manager, and for over a year, she has been contributing to cross-functional discussions aiming to embed inclusive research in the company’s approach to clinical trials.
Sarah is a pharmacist by training and obtained her Master’s Degree in regulatory affairs from the Paris-Sud University, France.
Disclosure information not submitted.
Tuesday, September 13, 2022
9:45 AM – 11:00 AM MST